drugset / Trial / NCT00695955
One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension
Non-randomizedOpen-labelTreatment
Summary
This purpose of this study is to evaluate the long-term safety and tolerability of azilsartan medoxomil in individuals with essential hypertension.
Timeline
- Start
- 2007-06
- Primary completion
- 2010-05
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azilsartan medoxomil | Other / unclassified | 80 mg | Oral |
| Background | Chlorthalidone | Other / unclassified | 25 mg | — |
| Background | Hydrochlorothiazide | Unknown | 12.5 mg | — |
| Background | Hydrochlorothiazide | Unknown | 25 mg | — |